Clinical Trials Logo

Filter by:
NCT ID: NCT05424900 Recruiting - Emotional Problem Clinical Trials

An Integrative Intervention for Preventing Children's Emotional Disorders

Start date: May 3, 2021
Phase: N/A
Study type: Interventional

The general objective of the study is to test an online platform for the prevention of emotional disorders in children aged 8-12 without any clinical symptoms.

NCT ID: NCT05424601 Not yet recruiting - Emotion Regulation Clinical Trials

Intervention in a Small-scale Study of Game Based Cognitive Change Skills

Start date: June 10, 2022
Phase: N/A
Study type: Interventional

This activity will have the objectives of preliminary testing user satisfaction, the feasibility of the platform and its preliminary efficacy

NCT ID: NCT05420233 Recruiting - Crohn Disease Clinical Trials

The CROCO Study: CROhn's Disease COhort Study

CROCO
Start date: August 1, 2021
Phase: N/A
Study type: Interventional

The investigators propose to create a prospective Crohn Disease cohort, where patients receiving the most up-to-date therapies with a treat-to-target strategy, will be closely followed to characterize the progression of Crohn Disease by measuring the Lémann Index over time. The goal of the CROCO Study - "Crohn's Disease Cohort Study" is to promote a greater understanding of the long-term evolution of Crohn Disease , to describe prospectively the impact of different therapeutic strategies and develop accurate predictors of bowel disease damage and disability.

NCT ID: NCT05418543 Recruiting - Bile Duct Cancer Clinical Trials

CH-EUS in Diagnosis of Inoperable Bile Duct Tumors

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

VALIDATION OF THE SUPERIORITY OF CONTRAST ENHANCED ENDOSCOPY TO STANDARD ENDOSCOPY IN THE DIAGNOSIS OF BILE DUCT TUMORS

NCT ID: NCT05414981 Recruiting - Chronic Hepatitis B Clinical Trials

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection

Start date: June 2022
Phase: Phase 1
Study type: Interventional

This is a randomized, blinded, placebo-controlled, dose-ranging Phase 1b study of the safety, PK, and antiviral activity of ABI-H3733 in treatment-naïve or off-treatment chronic Hepatitis B virus (cHBV) subjects that are Hepatitis B e antigen (HBeAg) positive or negative. The study will enroll up to 5 sequential cohorts of 10 subjects each, for a total of up to 50 subjects, randomized 8:2 to receive ABI-H3733 or placebo.

NCT ID: NCT05413083 Recruiting - Cirrhosis Clinical Trials

Evaluation of Cardiac Function in Acutely Decompensated Cirrhosis

DYNACORD-AD
Start date: June 6, 2022
Phase:
Study type: Observational [Patient Registry]

This is a prospective study of cardiocirculatory

NCT ID: NCT05396807 Not yet recruiting - Clinical trials for Metastatic Colon Cancer

REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

REVERT
Start date: June 2022
Phase: N/A
Study type: Interventional

This is a clinical prospective, no-Profit, Interventional, Premarket Medical Device "early phase", multicentre, single-arm study, based on collecting data on predictive biomarkers of mCRC patients, integrate them with the results of the retrospective evaluation of outcomes and profiles of historical mCRC patients previously treated in the Oncology Units, in order to evaluate the efficacy of the best administered treatment. Results from the retrospective evaluation, will serve to build an AI-based profile capable to identify "good" or "poor" responders to therapy and to support the clinician towards the best treatment option. AI is a software based on algorithm defined as Medical Device Class IIa.

NCT ID: NCT05366855 Recruiting - Clinical trials for Generalized Pustular Psoriasis

Long-Term Safety and Efficacy of Imsidolimab (ANB019) in Subjects With Generalized Pustular Psoriasis

GEMINI2
Start date: April 21, 2022
Phase: Phase 3
Study type: Interventional

This is a Phase 3, long term extension study to evaluate the safety and efficacy of imsidolimab compared with placebo in adult subjects with generalized pustular psoriasis (GPP).

NCT ID: NCT05352893 Recruiting - Clinical trials for Generalized Pustular Psoriasis

Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP

GEMINI1
Start date: April 14, 2022
Phase: Phase 3
Study type: Interventional

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of imsidolimab compared with placebo in adult subjects with generalized pustular psoriasis (GPP).

NCT ID: NCT05342766 Recruiting - Nutrient Deficiency Clinical Trials

Precision Nutrition

NP
Start date: May 1, 2022
Phase:
Study type: Observational [Patient Registry]

Determine the relationship between relevant genotypes and nutrient plasma levels, with the aim to normalize such levels using a nutritional intervention. (Original text in Romanian language: Caracterizarea precisa a relatiei dintre variatiile genetice si nivelul de nutrienti din sange/plasma/ser, in scopul de a defini modul in care aportul alimentar poate normaliza aceste nivele.)